Bulk and single-cell sequencing identified a prognostic model based on the macrophage and lipid metabolism related signatures for osteosarcoma patients
The introduction of multidrug combination chemotherapy has significantly advanced the long-term survival prospects for osteosarcoma (OS) patients over the past decades. However, the escalating prevalence of chemoresistance has emerged as a substantial impediment to further advancements, necessitatin...
Main Authors: | Zili Lin, Ziyi Wu, Wei Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024021224 |
Similar Items
-
Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages
by: Jincheng Wang, et al.
Published: (2022-07-01) -
Identification of an EMT‐related gene‐based prognostic signature in osteosarcoma
by: Haoli Gong, et al.
Published: (2023-06-01) -
Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma
by: Yi-jiang Song, et al.
Published: (2020-07-01) -
EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis
by: Zhenlin Dai, et al.
Published: (2023-02-01) -
Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
by: Xiaoyu Mao, et al.
Published: (2023-07-01)